Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adial Pharmaceuticals Inc...

    NASDAQ: ADILW · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Jul 27, 2023, 7:52 PM

    Adial Pharmaceuticals WT EXP 073123 Statistics

    Share Statistics

    Adial Pharmaceuticals WT EXP 073123 has - shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding n/a
    Shares Change (YoY) n/a
    Shares Change (QoQ) n/a
    Owned by Institutions (%) n/a
    Shares Floating n/a
    Failed to Deliver (FTD) Shares n/a
    FTD / Avg. Volume n/a

    Short Selling Information

    Short Interest n/a
    Short % of Shares Out n/a
    Short % of Float n/a
    Short Ratio (days to cover) n/a

    Valuation Ratios

    The PE ratio is -1.42 and the forward PE ratio is null. Adial Pharmaceuticals WT EXP 073123's PEG ratio is 0.02.

    PE Ratio -1.42
    Forward PE n/a
    PS Ratio 0
    Forward PS n/a
    PB Ratio 4.62
    P/FCF Ratio -2.71
    PEG Ratio 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Adial Pharmaceuticals WT EXP 073123.

    EV / Sales n/a
    EV / EBITDA n/a
    EV / EBIT n/a
    EV / FCF n/a

    Financial Position

    The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.

    Current Ratio 4.16
    Quick Ratio 4.16
    Debt / Equity 0
    Debt / EBITDA n/a
    Debt / FCF n/a
    Interest Coverage 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity n/a
    Return on Assets n/a
    Return on Invested Capital n/a
    Revenue Per Employee n/a
    Profits Per Employee n/a
    Employee Count undefined
    Asset Turnover 0
    Inventory Turnover n/a

    Taxes

    Income Tax n/a
    Effective Tax Rate 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0, so Adial Pharmaceuticals WT EXP 073123's price volatility has been lower than the market average.

    Beta 0
    52-Week Price Change n/a
    50-Day Moving Average 0.02
    200-Day Moving Average 0.17
    Relative Strength Index (RSI) 39.3
    Average Volume (20 Days) n/a

    Income Statement

    Revenue n/a
    Gross Profit n/a
    Operating Income -8.28M
    Net Income -13.2M
    EBITDA -8.28M
    EBIT n/a
    Earnings Per Share (EPS) -0.71
    Full Income Statement

    Balance Sheet

    The company has 3.75M in cash and 0 in debt, giving a net cash position of 3.75M.

    Cash & Cash Equivalents 3.75M
    Total Debt n/a
    Net Cash n/a
    Retained Earnings -82M
    Total Assets n/a
    Working Capital n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.92M and capital expenditures 0, giving a free cash flow of -6.92M.

    Operating Cash Flow -6.92M
    Capital Expenditures n/a
    Free Cash Flow -6.92M
    FCF Per Share -0.37
    Full Cash Flow Statement

    Margins

    Gross Margin n/a
    Operating Margin n/a
    Pretax Margin n/a
    Profit Margin n/a
    EBITDA Margin n/a
    EBIT Margin n/a
    FCF Margin n/a

    Dividends & Yields

    ADILW does not appear to pay any dividends at this time.

    Dividend Per Share n/a
    Dividend Yield n/a
    Dividend Growth (YoY) n/a
    Payout Ratio n/a
    Earnings Yield n/a
    FCF Yield n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ADILW.

    Price Target n/a
    Price Target Difference n/a
    Analyst Consensus n/a
    Analyst Count n/a
    Stock Forecasts

    Scores

    Altman Z-Score n/a
    Piotroski F-Score n/a

    Add to Watchlist